The FDA decision, scheduled for August 11, could mark a turning point in the treatment of PTSD. Concerns and criticisms surround the integrity of clinical trials, highlighting the lack of independent ...
Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock in August. The Food and Drug Administration (FDA) declined to approve a new drug application submitted ...
Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock on Tuesday when an expert panel overwhelmingly voted to recommend that the Food and Drug Administration ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results